SOSV is a global venture capital firm founded in 1995 and headquartered in New Jersey. The firm focuses on seed-to-growth investments in deep tech sectors, including biotech and life sciences, hardware and robotics, and cross-border software with emphasis on markets in Asia. It supports startups from early stages with investment capital as well as resources such as laboratories, collaborative spaces, and expert mentorship to accelerate product development and market traction. SOSV operates purpose-built programs to help portfolio companies raise follow-on funding, scale operations, and reach customers, often through structured matchmaking and access to a global network of investors. With a broad portfolio spanning hundreds of companies worldwide, SOSV aims to foster innovation, build vibrant entrepreneurial ecosystems, and contribute to sustainable technological advancement.

Founded in 2020, the European Innovation Council is a Brussels-based venture capital initiative that supports top innovators, entrepreneurs, small companies, and researchers with bright ideas. It co-invests with private investors in early-stage startups, prioritizes deep technology ventures, and pursues ESG-positive impacts to accelerate commercialization and scale-up.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore. It backs early and growth-stage technology, consumer and healthcare companies, applying deep industry knowledge and hands-on support to help portfolio companies scale. The firm manages US-dollar and RMB funds and maintains a global footprint, including a dedicated US arm, Qiming Venture Partners USA, to pursue cross-border opportunities in healthcare, therapeutics and digital health. Since inception, it has invested in more than 530 companies and achieved more than 200 exits via IPOs, M&A or other means, with over 70 portfolio companies reaching unicorn or super unicorn status. Qiming emphasizes long-term partnerships with entrepreneurs, aligning resources and networks to drive innovation and societal progress across its portfolio.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a nonprofit organization founded in 1982 that strengthens the Philadelphia region's technology ecosystem by providing capital, strategic guidance, and professional connections to technology startups and growth companies across Philadelphia, Bucks, Delaware, Chester, and Montgomery counties. It serves as a seed-stage capital provider and investor across information technology, health, and physical sciences, advancing technology commercialization through university–industry partnerships and regional initiatives. The organization aims to accelerate innovation, create jobs, and build a robust entrepreneurial community by offering funding, mentorship, and access to a broad network of resources.

Khosla Ventures is a California-based venture capital firm founded in 2004 and headquartered in Menlo Park. It provides capital and strategic guidance to technology companies across stages, investing in sectors including artificial intelligence, digital health, sustainability, climate tech, and consumer technology. The firm seeks startups with innovative technologies or business models and offers hands-on support to help build enduring companies. It manages multiple funds and runs initiatives such as Khosla Impact, which supports high-impact for-profit ventures addressing the needs of low-income populations and emerging markets. Through funding and guidance, it backs transformative technologies and scalable businesses in the United States and globally.

OrbiMed is a global healthcare investment firm founded in 1989 and based in New York, with a worldwide presence that includes offices in several regions. It allocates capital across private equity, venture capital, and public equity to support healthcare companies at various stages, from startups to established firms. Its focus spans biopharmaceuticals, medical devices, diagnostics, life sciences tools, and digital health, as well as healthcare services. The firm pursues opportunities across major markets in North America, Europe, and Asia, often leveraging region-specific teams to invest in companies in Israel, China, India, South Korea, and other jurisdictions. OrbiMed emphasizes building world-class companies by providing strategic financing, industry expertise, and global resources to portfolio companies in pursuit of medical breakthroughs and sustainable growth.

Alumni Ventures is a venture capital firm founded in 2014 and based in Manchester, New Hampshire. It connects accredited individual investors with startup deals and co-invests alongside established venture capital firms across multiple stages, from seed to growth. The firm provides access to diversified portfolios through funds, syndicates, and investing clubs, supported by a large network of community members and individual investors. It invests across sectors and geographies, with a focus on transparency and due diligence in collaborative investments with leading firms such as Andreessen Horowitz, Sequoia, and Y Combinator. Alumni Ventures operates internationally with offices in New York, Boston, Menlo Park, Chicago, London, and Tokyo and has raised substantial capital to back founders with strategic capital and resources.

High-Tech Gründerfonds is a Germany-based venture capital firm that provides seed and early-stage financing to technology-focused startups. Founded in 2005, it operates as a public-private partnership with government and corporate investors to support German and European tech companies across digital technology, industrial tech, life sciences, chemistry and related areas. The firm offers capital and expertise to help startups move from concept to market, typically engaging in initial rounds and follow-on funding to accelerate growth. Since inception it has backed hundreds of startups and supported follow-on rounds, helping to stimulate innovation and entrepreneurship in Germany.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with a global investment reach. It provides capital and operational support to early, growth, and later-stage companies across a wide range of industries, including software, consumer technology, healthcare technology, life sciences, energy technology, infrastructure, and AI-enabled services. NEA collaborates with founders to address technical challenges, guide product development, and expand markets, leveraging its domain expertise to help portfolio companies scale from seed stages through IPO. The firm invests across the United States, Asia, and other regions, often supporting companies from early stages to scale, and has a long track record that includes numerous IPOs and acquisitions. NEA emphasizes a hands-on partnership approach and seeks opportunities across sectors that enable transformational businesses through technology and data-driven innovation.

HealthTech Capital is a membership-based angel investor network and mentoring program founded in 2010 and based in Los Altos Hills, California. It connects accredited angel investors with early-stage health technology and medical technology startups, healthcare systems, venture and corporate partners, and clinical providers to foster deal flow and collaboration. The organization supports portfolio companies through mentoring, networking initiatives, and access to its broad network across the United States and Asia, with activities that combine funding and guidance to accelerate the development of innovative healthcare technologies at the intersection of healthcare, technology and mobility.

Innovation Works is a Pittsburgh-based nonprofit economic development organization founded in 1988 to foster growth of early-stage technology startups in Southwestern Pennsylvania. It provides funding, mentorship, and programs across software, robotics, hardware, and life sciences, and supports manufacturers in adopting new technologies. As an affiliate of Ben Franklin Technology Partners, it combines resources with regional partners to build an innovation ecosystem, offering accelerator programs such as AlphaLab Robotics Factory and connections to investors and industry experts. Through its programs, Innovation Works aims to create jobs and drive regional prosperity by helping startups scale from seed stage to follow-on funding.

Deerfield Management is a New York-based healthcare investment firm focused on long-term, structured investments in public and private healthcare companies. Founded in 1994, it manages a diversified portfolio spanning therapeutics, medical devices, diagnostics, digital health, and health services. The company combines investment activity with information services and philanthropy, leveraging Deerfield Intelligence, an approach that uses AI, data, and market research to inform decisions. It supports innovation through initiatives such as Deerfield Discovery and Development and the Deerfield Foundation, which aims to improve children's health worldwide. Through its capital and strategic insight, Deerfield seeks to connect capital, ideas, and technology to advance human health.

Legend Capital is a Beijing-based venture capital firm and the investment arm of Legend Holdings, founded in 2001 to back high-growth technology and related companies in China and markets connected to China. The firm concentrates on early-stage IT, telecommunications, media, healthcare, consumer services, modern services, and sectors such as infrastructure, clean technology, and advanced manufacturing. It provides portfolio companies with strategic resources, market access support, and tailored services to help with business development, branding, and navigating the Chinese market, aiming to create value and maximize returns for investors.

Keiretsu Forum is a global investment community of accredited private equity investors, venture capitalists, and corporate/institutional investors. It operates as an international network with chapters in numerous regions, connecting members through private equity funding, deal flow, and related activities. Members review opportunities presented through restricted forums and may invest in selected companies. The organization supports collaboration by providing access to capital, resources, and mentoring through its events and partnerships.

Eli Lilly and Company is a global biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing medicines across neuroscience, cardiometabolic, cancer, and immunology. The company operates manufacturing and distribution facilities in the United States, Puerto Rico, and multiple countries, with products sold in about 135 markets worldwide. Through ongoing research and development, Lilly aims to deliver therapies that improve patient outcomes and access to medicines. Its portfolio includes treatments such as Mounjaro and Jardiance for cardiometabolic diseases, Verzenio and Jaypirca for cancer, Trulicity and Humalog for diabetes, and Taltz and Olumiant for immunology, among others. Lilly emphasizes safety and quality in manufacturing and supports patients through educational and support initiatives, reflecting a long history of pharmaceutical leadership and a commitment to advancing personalized medicine.

IP Group is a global science and technology investment company focused on identifying, backing, and growing early‑stage, science‑based businesses. It commercialises intellectual property originating from research‑intensive institutions, managing the process from IP discovery to business development or the formation of strategic partnerships. The firm concentrates on HealthTech, DeepTech, and CleanTech, backing university spin‑outs and other innovative ventures with the potential to disrupt markets and deliver strong financial returns while delivering social and environmental impact aligned with the UN Sustainable Development Goals. IP Group leverages expertise in investment case development, governance, results reporting, and regulatory affairs, and cultivates collaborations with leading research institutions to accelerate growth. As a catalyst for innovation, it provides capital, strategic guidance, and operational support to portfolio companies to translate scientific advances into scalable technologies that benefit society and the economy.

Shenzhen Capital Group is a government-backed venture capital and private equity firm based in Shenzhen, established in 1999. It concentrates on early-stage and growth investments in information technology, internet, new media, biopharma, new energy, environmental protection, advanced materials, high-end equipment manufacturing, and consumer sectors, with a focus on SMEs and enterprises in emerging industries. The firm seeks long-term value creation through active portfolio development, including post-investment services that support growth and commercialization. Beyond direct investments, it manages broader capitalization activities such as mutual funds, real estate funds, and asset securitization. Shenzhen Capital Group has built a large, diversified portfolio and has supported numerous companies through to initial public offerings in domestic and international markets.

SFC Capital is a United Kingdom-based venture capital firm, founded in 2012, that backs early-stage startups across sectors such as software, technology, e-commerce, consumer, enterprise, fintech, healthcare, and digital health. It provides capital and strategic support to seed and pre-seed companies and operates primarily in the UK, with activity centered in London and Northwich.

Innova Memphis is a Tennessee-based venture capital firm founded in 2007 with roots in the Memphis Bioworks Foundation. It focuses on pre-seed, seed, and early-stage investments in high-growth biosciences, technology, and agri-tech companies in Tennessee. The firm supports startups from concept to market by providing capital, strategic guidance, and access to industry networks, including connections with established corporations for licensing, buy-outs, or further investments. By combining experienced management, market expertise, and venture capital, Innova Memphis aims to accelerate product development and create viable business units capable of standing independently and collaborating with mature market leaders when appropriate.

RA Capital Management is a Boston-based investment management firm specializing in growth-oriented and early-stage support for healthcare, life sciences, and planetary health companies. The company deploys capital across private seed rounds, series financings, and public markets, with a focus on drugs, medical devices, diagnostics, and tools that advance patient care. It leverages a science-driven approach through its research platform TechAtlas and provides value-added services such as board representation, executive recruitment, and market intelligence to portfolio companies. The firm operates an incubator program called Raven to nurture biomedical innovation and maintains an Innovator Resources program to guide company development. RA Capital emphasizes evidence-based investing, long-term partnerships, and social responsibility, aiming to drive value creation from inception through commercialization.

Versant Ventures is a healthcare-focused venture capital firm founded in 1999 and headquartered in San Francisco, with offices in Canada, the United States, and Europe. The firm invests across the healthcare sector at all stages, with emphasis on the discovery and development of novel therapeutics, including pharmaceuticals, biotechnology, medical devices, and life sciences. Versant combines investment, operating, and scientific expertise to support portfolio companies through strategic guidance and hands-on involvement in company building. The firm manages substantial capital, enabling a hands-on approach to helping entrepreneurs build durable companies addressing high unmet medical needs.

Gilde Healthcare is a European specialist private investment firm focused on healthcare, based in Utrecht with offices in Germany and the United States. It manages multiple funds across venture and growth in healthcare, private equity in healthcare, and climate solutions, with a long history dating back to the 1980s. The firm invests in healthcare technologies and services across Europe and North America, including medtech, pharmaceuticals, diagnostics, digital health, therapeutics, and outsourced healthcare services. It supports both early and growth-stage companies through buyouts and growth equity, aiming to build established, profitable businesses and enable scale. The investment approach emphasizes impactful companies and responsible practices, with a transatlantic footprint to source and develop opportunities.

Parkwalk Advisors is a London-based venture capital firm focused on investing in UK university spinouts and other research-intensive technology companies across sectors such as artificial intelligence, big data, life sciences, cleantech, materials, medical technology, quantum computing and the future of mobility. The firm targets early- to growth-stage opportunities and typically engages in seed to growth capital rounds, prioritizing UK-based companies originating from university research. Parkwalk leverages academic networks, technology transfer offices and venture ecosystems to access high-quality deal-flow and supports portfolio companies through development toward scale. Founded in 2009, Parkwalk operates in connection with IP Group, a university IP commercialisation company.

Panakes Partners is an independent venture capital firm based in Milan, Italy, that focuses on early-stage investments in life sciences and healthcare companies across Europe and Israel. It provides capital and hands-on support to entrepreneurs and scientific teams, leveraging a network of clinicians and industry experts to help portfolio companies advance products and reach clinical and commercial milestones. The firm’s activity spans dermatology, oncology, cardiovascular disease, and neurology, and it emphasizes sustainable impact through ESG principles and adherence to broader European innovation programs.

European Investment Fund is the European Union’s financing arm for small and medium-sized enterprises and mid-caps, providing financial instruments to improve access to affordable financing throughout a business lifecycle. It leverages its capital base to attract private investment through guarantees and equity funding, fostering public-private partnerships and crowding in lenders and investors to support SMEs and startups across EU member states, candidate countries, and EFTA. The EIF focuses on innovation, growth, competitiveness, social impact, and sustainability, and supports financing for sectors such as information technology, life sciences, energy, and manufacturing, helping close funding gaps and contribute to Europe’s economic resilience and strategic autonomy.

Arboretum Ventures is a Michigan-based venture capital firm that backs healthcare startups across the United States, with a particular emphasis on the Midwest. It operates across seed, early, mid-stage, and growth investments in areas such as services, medical devices, diagnostics, healthcare information technology, therapeutics, and life science tools, including tech-enabled care delivery. The firm typically makes equity investments in the five to fifteen million dollars range and provides active portfolio support to improve patient outcomes and reduce healthcare costs.

Sand Hill Angels is a member-driven angel investor group based in Mountain View, California, with a 60-plus member network that supports early-stage technology startups. Founded around 2000, the group provides seed to Series A funding, mentorship, and meaningful connections to customers, partners, and venture capital firms to help startups scale. Typical investments range from $300,000 to $500,000 in rounds with pre-money valuations under $5 million, and it backs companies across sectors such as semiconductors, enterprise software, storage, and communications, as well as clean technology, internet, information sciences, and life sciences including medical devices, diagnostics, and bioinformatics. Sand Hill Angels collaborates with other venture funds and angel organizations to foster the Bay Area ecosystem and broader North American tech growth, sourcing deals and building long-term partnerships.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

Kurma Partners is a Paris-based investment firm focused on financing innovation in healthcare and biotechnology across development stages, from early discovery to later-stage growth. It backs therapeutics, diagnostics, health technology, and digital health ventures in Europe, leveraging ties with research centers and hospitals to translate scientific advances into clinical and commercial success. The firm operates with a Europe-wide reach, with a notable presence in France, and emphasizes collaborating with researchers and entrepreneurs to support impactful, sustainable healthcare solutions.

MassVentures is a Massachusetts-based venture capital firm that provides seed and early-stage funding to high-growth startups in the Massachusetts innovation economy, helping concepts move from idea to commercialization. Founded in 1978 as a quasi-public corporation by the Legislature of the Commonwealth, it is governed by an independent board and managed by experienced venture investors. The firm focuses on information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics sectors in Massachusetts and operates accelerator programs to support portfolio companies. MassVentures leverages the state's entrepreneurial ecosystem, educated workforce, and centers of innovation to back early-stage ventures.

U.S. Venture Partners is a venture capital firm based in Menlo Park, California, founded in 1981. It focuses on early-stage investments in information technology and health care, with interests in enterprise software, IT security, consumer internet, mobile, e-commerce, healthcare, and IT-enabled healthcare services. The firm supports entrepreneurs in turning ideas into world-changing companies and has built a team with backgrounds as former entrepreneurs, technologists, corporate executives, financial professionals, and industry experts. USVP backs businesses primarily on the West Coast and beyond, investing in software, healthcare, cybersecurity, and related technology sectors across the United States and Israel.

Novo Nordisk is a global healthcare company focused on discovering, developing, and delivering medicines for chronic diseases, with insulin and diabetes care at its core. It develops and distributes insulin and other diabetes therapies, and invests heavily in scientific research and biotechnology to advance breakthroughs. The company operates worldwide, aiming to expand access to its treatments and improve patient outcomes, while emphasizing sustainability, partnerships, and social responsibility.

SV Health Investors is a US-headquartered private equity and venture capital firm focused on healthcare and life sciences. Formerly known as SV Life Sciences, it invests in therapeutics, biotechnology, medtech, and healthcare growth companies across North America and Western Europe, with offices in Boston, San Francisco, and London. Founded in 1993, the firm aims to transform healthcare by backing entrepreneurs who develop breakthrough treatments and technologies, supported by a team of investment professionals and operating partners. It has managed billions of dollars in capital across private healthcare funds, pursuing a strategy that combines early-stage and growth investments and seeks value through strategic partnerships, acquisitions, and, when appropriate, public offerings. The firm operates as a dedicated partner to innovators in the sector, helping translate scientific advances into patient impact and commercial success.

Sofinnova Partners is an independent venture capital firm based in Paris, France, focusing on life sciences. It finances start-ups, early-stage companies, corporate spin-offs, and occasional turnarounds in biopharmaceuticals, biotech, medical devices, and related areas. The firm often acts as a lead or cornerstone investor and is frequently the first institutional backer in Series A rounds, maintaining an active role including board seats from formation through exit. It pursues global opportunities and emphasizes thorough due diligence on portfolio companies, including management and intellectual property considerations. The firm was established in 1972.

Almi Invest is a Swedish early-stage venture capital firm and part of the Almi Group. It funds startups across sustainability, industry, technology, and life sciences, from pre-seed to Series A, and typically co-invests with independent private investors to accelerate growth. The firm provides strategic guidance, active board participation, and access to a broad investor network to help portfolio companies scale. As part of Almi Group, Almi Invest collaborates with public funds and regional partners to support entrepreneurs and promote sustainable economic development in Sweden.

SDIC Innovation Investment Management is the private equity and venture capital arm of State Development & Investment Corp. It makes investments across technology and manufacturing sectors, including mobile internet, internet of things, cloud computing, big data, information technology services, industrial robotics, and intelligent manufacturing. The firm also targets high-end medical equipment, diagnostics, high-value consumables, modern agricultural equipment, ships and marine engineering, new materials, clean energy, energy conservation, and healthcare; for new energy vehicles it focuses on intelligent upstream and downstream supply chains, power batteries and systems, and related technologies. Founded in 2009, the company is based in Beijing with an additional office in Asia. The firm aims to support development and deployment of innovative technologies through private equity and venture capital investments.

IDG Capital is a venture capital and private equity investment firm focused on funding technology companies across early to growth stages. It blends global perspective with deep local expertise in China and Asia, mobilizing international resources to support inbound and outbound opportunities. Headquartered in Hong Kong and established in 1993, the firm has built one of the first institutional investment platforms in China and maintains relationships with influential business leaders. It works with private equity and venture capital fund managers, investment advisors, and entities worldwide, managing funds in USD and RMB and backing portfolio companies with a long-term value approach, particularly in software, information technology, and related sectors.

Morningside Group is a venture capital firm founded in 1986, originally established as a family office for the Chan family, and is based in the greater Boston area. The firm makes venture investments in companies with novel science and technology, pursuing a long-term, patient approach to company-building and emphasizing ethical practices. Its investment focus spans life sciences, digital health, artificial intelligence, materials science, and information technology. In addition to its investment activities, Morningside supports charitable initiatives in education, research, and healthcare, with partnerships including the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Mercia Asset Management is a UK-based asset management firm focused on equity and debt investments. It cultivates a diversified program across venture, private equity and debt, marketed as a Complete Capital Solution, to deliver returns for business owners, shareholders and fund investors. Headquartered in Henley-in-Arden, the firm backs growth-oriented companies across sectors including digital entertainment, electronics, materials, manufacturing, engineering, life sciences and biosciences, software and e-commerce, and the internet. Founded in 1982, Mercia Asset Management operates in the United Kingdom with a long-standing emphasis on supporting growth companies through capital at various stages.

ShangBay Capital is a Palo Alto‑based venture capital firm, founded in 2015, focused on early‑stage investments in healthcare technology. The firm backs companies operating in life sciences, medical devices, biotechnology, and mobile health, across the United States, and emphasizes disruptive healthcare innovation. With a team that collaborates closely with founders, ShangBay Capital seeks to address unmet clinical needs, navigate regulatory pathways, and pursue strategic exits to generate substantial value. It maintains active involvement in portfolio companies through expertise in global market opportunities, valuation, and growth acceleration, aiming to deliver strong returns for investors.

Right Side Capital Management is a San Francisco-based venture capital firm that focuses on early-stage technology companies, emphasizing capital-efficient startups across the United States and Canada. The firm targets pre-product-market-fit ventures and typically funds rounds in the tens of thousands to low hundreds of thousands of dollars, with round sizes commonly ranging from 50K to 500K. It employs a data-driven, rapid decision process and makes a high volume of investments annually, aiming to provide a firm yes or no within roughly two weeks. The team comprises seasoned founders who bring hands-on experience, and the firm operates like an operating company, delivering post-investment support and broad diversification across a large portfolio. Its activity spans multiple states beyond traditional hubs, reflecting a broad geographic reach and an emphasis on backing entrepreneurs overlooked by mainstream venture capital.

Aperture Venture Partners is a New York-based venture capital firm established in 2002 that specializes in the healthcare sector, with focus on medical devices, biopharmaceuticals, healthcare IT/services, and diagnostics. The firm supports entrepreneurs addressing significant health-related challenges and advancing opportunities in healthy living. It pursues early-stage investments, with initial checks typically ranging from 1 million to 5 million dollars, and seeks opportunities across the United States. Managed by experienced leaders in healthcare and investment, the firm emphasizes building companies with meaningful growth and market impact in their sectors.

Mayo Clinic is a non-profit medical organization based in Rochester, Minnesota, established in 1864. It provides medical care across a wide range of specialties, supports education in clinical medicine and the medical sciences, and conducts extensive medical research through programs nationwide. The organization operates as a physician-led group practice and maintains entities such as Mayo Clinic Ventures, which translates inventions into patient care and educational and research initiatives, and Mayo Clinic Platform, an accelerator and incubator focused on health technology and artificial intelligence startups.

Samsung Electronics is a global technology company headquartered in South Korea that designs, manufactures, and sells a wide range of electronics and components. Its products include mobile devices, consumer electronics, home appliances, displays, memory and storage, and computing devices, and it is a leading producer of semiconductor chips. The company operates worldwide across consumer, enterprise, and telecommunications markets and engages in research and development, manufacturing, logistics, and repair services. It maintains activities in areas such as information technology, mobile communications, device solutions, and chip fabrication, supported by extensive capabilities in advanced materials, display tech, and AI-powered services. Samsung is known as a major global supplier and innovator in mobile, television, and semiconductor sectors, with a diversified portfolio and global reach that underpins its position in the technology industry.

Hatteras Venture Partners is a North Carolina-based venture capital and private equity firm focused on life sciences and healthcare companies in the United States. Founded in 2000 and headquartered near Durham and the Research Triangle Park, the firm targets biopharmaceuticals, medical devices, diagnostics, healthcare IT, and related human medicine opportunities. It backs companies across early to growth stages, typically investing in seed to mid-stage rounds and pursuing co-investment opportunities. The team brings operational experience and a track record of helping portfolio companies advance research, development, and commercialization. The firm concentrates its activity in the Southeast and Mid-Atlantic regions, emphasizing opportunities in capital-underserved, research-driven markets.

Ally Bridge Group is a private investment group focusing on healthcare and life sciences. It pursues venture, growth equity, and buyout opportunities in both private and public markets. The firm targets innovative life science companies spanning pharmaceuticals, medical devices, diagnostics, and healthcare IT, with emphasis on transformative therapies and disruptive platforms. It operates globally, with offices in Hong Kong and the United States, and was founded in 2013. The firm supports portfolio companies through strategic guidance and an extensive network to bridge innovations to global markets.

Lumira Ventures is a North American healthcare and life sciences venture capital firm with offices in Toronto, Montreal, Vancouver and Boston. It backs entrepreneurial management teams developing biotherapeutics, medical devices, digital health and related life sciences companies in Canada and the United States. The firm typically invests in mid to late-stage opportunities, supporting portfolio companies with financings, active board participation and access to additional funding, partnerships and market reach. Since its founding, Lumira Ventures has invested in more than 100 healthcare companies and maintains a portfolio of over 30 active investees across North America. By partnering with mission-driven entrepreneurs, Lumira aims to accelerate innovation and create transformative impact for patients and communities worldwide.

Matrix Partners is a venture capital firm founded in 1977 and based in San Francisco that funds early-stage technology companies. The firm focuses on applied AI, B2B software, fintech, health tech, infrastructure and hardware, and supports ventures from idea to Series A with a hands-on, founder-friendly approach drawn from its team of former entrepreneurs. It has backed and partnered with companies such as Apple, FedEx, Oculus, Canva, Zendesk and HubSpot, Postmates and Fivetran, illustrating a history of broad technology investments across the United States, China and India. Matrix Partners combines local knowledge with global experience to help portfolio companies scale into category-leading businesses.

Vivo Capital is a global healthcare investment firm founded in 1996 and based in Palo Alto, California, with offices in Asia. It operates a multi-fund platform spanning growth equity, private equity including buyouts, venture capital, and public equity, and invests broadly in biotechnology, pharmaceuticals, medical devices, and healthcare services across major markets. The firm pursues opportunities worldwide, supporting companies at various development stages with a team of physicians, scientists, entrepreneurs, operating executives, and industry experts who contribute deep sector insight. It manages approximately $5.8 billion in assets under management.

Canaan Partners is a global venture capital firm founded in 1987 and based in Menlo Park, California, with East Coast offices in Westport, Connecticut and an international presence in Israel and India. It focuses on early-stage investments in technology and healthcare companies, targeting sectors such as fintech, enterprise software and cloud, marketplaces, frontier tech, biopharma, digital health and medtech. The firm emphasizes close collaboration with founders, providing strategic guidance and hands-on support to help portfolio companies grow and scale. Over its history it has funded hundreds of startups across information technology and life sciences, building a diversified portfolio and a track record of supporting transformative ideas from inception to growth.